{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:35Z","timestamp":1790890175847,"version":"4.1.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.pharmthera.2019.107455","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T22:21:58Z","timestamp":1576707718000},"page":"107455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease \u2013 Potential pathogenetic mechanism and therapeutic implications"],"prefix":"10.1016","volume":"207","author":[{"given":"Yutaka","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.107455_bb0005","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1084\/jem.20172045","article-title":"A role for astroglia in prion diseases","volume":"214","author":"Aguzzi","year":"2017","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nri3553","article-title":"The immunobiology of prion diseases","volume":"13","author":"Aguzzi","year":"2013","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","article-title":"Amyloid-\u03b2 oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors","volume":"47","author":"Alberdi","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.neuro.2006.12.001","article-title":"Serum chemical elements and oxidative status in Alzheimer\u2019s disease, Parkinson disease and multiple sclerosis","volume":"28","author":"Alimonti","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0025","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3390\/met5042070","article-title":"Iron, aging, and neurodegeneration","volume":"5","author":"Angelova","year":"2015","journal-title":"Metals"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coph.2018.11.006","article-title":"Therapeutic strategies for prion disease: A practical perspective","volume":"44","author":"Appleby","year":"2019","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/nbdi.2002.0496","article-title":"Increased lipid peroxidation in cerebrospinal fluid and plasma from patients with Creutzfeldt-Jakob disease","volume":"10","author":"Arlt","year":"2002","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10534-009-9277-5","article-title":"Serum zinc is decreased in Alzheimer\u2019s disease and serum arsenic correlates positively with cognitive ability","volume":"23","author":"Baum","year":"2010","journal-title":"Biometals"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/abbs\/gmt044","article-title":"Amyloid-\u03b2 peptide (1-42) aggregation induced by copper ions under acidic conditions","volume":"45","author":"Bin","year":"2013","journal-title":"Acta Biochimica et Biophysica Sinica"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0050","doi-asserted-by":"crossref","first-page":"17140","DOI":"10.1074\/jbc.M112.344093","article-title":"Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro","volume":"287","author":"Bornhorst","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-017-1670-5","article-title":"Prion disease: Experimental models and reality","volume":"133","author":"Brandner","year":"2017","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0060","doi-asserted-by":"crossref","first-page":"12831","DOI":"10.1074\/jbc.M709820200","article-title":"Manganese binding to the prion protein","volume":"283","author":"Brazier","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1471-4159.2010.06771.x","article-title":"Manganese chelation therapy extends survival in a mouse model of M1000 prion disease","volume":"114","author":"Brazier","year":"2010","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrn3887","article-title":"Spreading of pathology in neurodegenerative diseases: A focus on human studies","volume":"16","author":"Brettschneider","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0075","article-title":"Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer\u2019s disease","volume":"2013","author":"Brewer","year":"2013","journal-title":"International Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-8118-11-10","article-title":"A new look at cerebrospinal fluid circulation","volume":"11","author":"Brinker","year":"2014","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1042\/bst0300742","article-title":"Metal toxicity and therapeutic intervention: Copper and prion diseases","volume":"30","author":"Brown","year":"2002","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0090","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1042\/BST20130130","article-title":"\u03b1-Synuclein as a ferrireductase","volume":"41","author":"Brown","year":"2013","journal-title":"Biochemical Society Transactions"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0095","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuroscience.2004.07.003","article-title":"Molecular mechanisms of cerebrospinal fluid production","volume":"129","author":"Brown","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.nbd.2011.12.020","article-title":"Copper is toxic to PrP-ablated mice and exacerbates disease in a mouse model of E200K genetic prion disease","volume":"45","author":"Canello","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0105","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.02952-14","article-title":"Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction","volume":"89","author":"Carroll","year":"2015","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005551","article-title":"Prion strain differences in accumulation of PrPSc on neurons and glia are associated with similar expression profiles of neuroinflammatory genes: Comparison of three prion strains","volume":"12","author":"Carroll","year":"2016","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0115","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1091\/mbc.e11-04-0321","article-title":"Neuroprotective role of PrPC against kainate-induced epileptic seizures and cell death depends on the modulation of JNK3 activation by GluR6\/7-PSD-95 binding","volume":"22","author":"Carulla","year":"2011","journal-title":"Molecular Biology of the Cell"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3233\/JAD-2011-101959","article-title":"Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease","volume":"25","author":"Chalbot","year":"2011","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0125","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.2174\/138161209789271825","article-title":"RING finger E(3) ubiquitin ligases: Structure and drug discovery","volume":"15","author":"Chasapis","year":"2009","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcb.20547","article-title":"Elucidation of ATP-stimulated stress protein expression of RBA-2 type-2 astrocytes: ATP potentiate HSP60 and Cu\/Zn SOD expression and stimulates pI shift of peroxiredoxin II","volume":"97","author":"Chen","year":"2006","journal-title":"Journal of Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.12688\/f1000research.7431.1","article-title":"Metals and neurodegeneration","volume":"5","author":"Chen","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuroscience.2015.05.035","article-title":"\u03b1-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with reduced inward current and Ca2+ influx upon NMDA stimulation","volume":"300","author":"Chen","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0145","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1471-4159.2011.07460.x","article-title":"\u03b1-Synuclein promotes clathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death","volume":"119","author":"Cheng","year":"2011","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S0317167100002389","article-title":"Early olfactory involvement in Alzheimer's disease","volume":"30","author":"Christen-Zaech","year":"2003","journal-title":"The Canadian Journal of Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0155","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.envres.2017.07.048","article-title":"Metals and neurodegenerative diseases. A systematic review","volume":"159","author":"Cicero","year":"2017","journal-title":"Environmental Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20121898","article-title":"The cell biology of prion-like spread of protein aggregates: Mechanisms and implication in neurodegeneration","volume":"452","author":"Costanzo","year":"2013","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0165","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbamcr.2006.05.003","article-title":"Activation of superoxide dismutases: Putting the metal to the pedal","volume":"1763","author":"Culotta","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1085\/jgp.201411302","article-title":"Glycine-dependent activation of NMDA receptors","volume":"145","author":"Cummings","year":"2015","journal-title":"The Journal of General Physiology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0175","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1046\/j.1460-9568.2003.02662.x","article-title":"Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease","volume":"17","author":"Cunningham","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0180","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0185","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1021\/bi900170n","article-title":"Thermodynamic and voltammetric characterization of the metal binding to the prion protein: Insights into pH dependence and redox chemistry","volume":"48","author":"Davies","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/1567205011310030010","article-title":"BACE1 levels by APOE genotype in non-demented and Alzheimer\u2019s post-mortem brains","volume":"10","author":"Decourt","year":"2013","journal-title":"Current Alzheimer Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0195","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.1073\/pnas.0702662104","article-title":"Formation of native prions from minimal components in vitro","volume":"104","author":"Deleault","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0200","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0205","doi-asserted-by":"crossref","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","article-title":"Extracellular \u03b1-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation","volume":"32","author":"Di\u00f3genes","year":"2012","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0215","article-title":"Decreased circulating Zinc levels in Parkinson\u2019s disease: A meta-analysis study","volume":"7","author":"Du","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jtemb.2014.05.007","article-title":"The neurotoxicity of iron, copper and manganese in Parkinson\u2019s and Wilson\u2019s diseases","volume":"31","author":"Dusek","year":"2015","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0225","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: A randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008117","article-title":"Development of a new largely scalable in vitro prion propagation method for the production of infectious recombinant prions for high resolution structural studies","volume":"15","author":"Era\u00f1a","year":"2019","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2009-0920","article-title":"Midlife coffee and tea drinking and the risk of late-life dementia: A population-based CAIDE study","volume":"16","author":"Eskelinen","year":"2009","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0240","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/femsre\/fuw004","article-title":"The 'liaisons dangereuses' between iron and antibiotics","volume":"40","author":"Ezraty","year":"2016","journal-title":"FEMS Microbiology Reviews"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0245","doi-asserted-by":"crossref","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington\u2019s disease","volume":"29","author":"Fan","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0250","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer\u2019s Disease: Additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/brain\/awq314","article-title":"SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse","volume":"134","author":"Fischer","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052664","article-title":"Cerebrospinal fluid pressure decreases with older age","volume":"7","author":"Fleischman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0265","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1073\/pnas.162195499","article-title":"Tetracyclines affect prion infectivity","volume":"99","author":"Forloni","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0270","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pone.0000334","article-title":"Mechanisms of copper ion mediated Huntington\u2019s disease progression","volume":"2","author":"Fox","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","article-title":"Sporadic and familial CJD: Classification and characterisation","volume":"66","author":"Gambetti","year":"2003","journal-title":"British Medical Bulletin"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0280","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/brain\/awt152","article-title":"The coeruleus\/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease","volume":"136","author":"Garc\u00eda-Lorenzo","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ejcn.1602495","article-title":"Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study","volume":"61","author":"van Gelder","year":"2007","journal-title":"European Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0290","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2008.05.002","article-title":"Trace elements in serum from patients with Parkinson\u2019s disease\u2014A prospective case-control study: The Nord-Tr\u00f8ndelag Health Study (HUNT)","volume":"1219","author":"Gellein","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0295","doi-asserted-by":"crossref","first-page":"36341","DOI":"10.1074\/jbc.M704447200","article-title":"Selective incorporation of polyanionic molecules into hamster prions","volume":"282","author":"Geoghegan","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0300","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255555","article-title":"Neurodegeneration. Alzheimer\u2019s and Parkinson\u2019s diseases: The prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","article-title":"The propagation of prion-like protein inclusions in neurodegenerative diseases","volume":"33","author":"Goedert","year":"2010","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2014.12.009","article-title":"Prion degradation pathways: Potential for therapeutic intervention","volume":"66","author":"Goold","year":"2015","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0315","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/2151043a0","article-title":"Self-replication and scrapie","volume":"215","author":"Griffith","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0320","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2202-15-44","article-title":"Microglial Cx3cr1 knockout reduces prion disease incubation time in mice","volume":"15","author":"Grizenkova","year":"2014","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0325","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1021\/bi7000032","article-title":"Metal ions differentially influence the aggregation and deposition of Alzheimer\u2019s \u03b2-amyloid on a solid template","volume":"46","author":"Ha","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1474-4422(13)70307-7","article-title":"Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomised, double-blind, placebo-controlled trial","volume":"13","author":"Ha\u00efk","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0335","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1089\/ars.2012.5032","article-title":"A low-molecular-weight ferroxidase is increased in the CSF of sCJD cases: CSF ferroxidase and transferrin as diagnostic biomarkers for sCJD","volume":"19","author":"Haldar","year":"2013","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2009.05118.x","article-title":"The progression of pathology in Parkinson\u2019s disease","volume":"1184","author":"Halliday","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0345","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2202-10-110","article-title":"Regulation of cerebrospinal fluid production by caffeine consumption","volume":"10","author":"Han","year":"2009","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0350","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0304-3940(01)01574-9","article-title":"Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease","volume":"300","author":"Haussermann","year":"2001","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tics.2010.12.005","article-title":"Cognitive neuroscience of self-regulation failure","volume":"15","author":"Heatherton","year":"2011","journal-title":"Trends in Cognitive Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jtemb.2004.09.003","article-title":"Serum trace element levels and the complexity of inter-element relations in patients with Parkinson\u2019s disease","volume":"18","author":"Hegde","year":"2004","journal-title":"Journal of Trace Elements in Medicine and Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0365","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.mcn.2007.12.008","article-title":"Elevated manganese levels in blood and CNS in human prion disease","volume":"37","author":"Hesketh","year":"2008","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0370","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2527\/jas.2006-714","article-title":"Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy","volume":"85","author":"Hesketh","year":"2007","journal-title":"Journal of Animal Science"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0375","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0380","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1176\/jnp.23.2.jnp206","article-title":"Huntington\u2019s disease: Effect of memantine on FDG-PET brain metabolism?","volume":"23","author":"Hjermind","year":"2011","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2011.01.003","article-title":"Patterns of levels of biological metals in CSF differ among neurodegenerative diseases","volume":"303","author":"Hozumi","year":"2011","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0390","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1515\/BC.2003.142","article-title":"No superoxide dismutase activity of cellular prion protein in vivo","volume":"384","author":"Hutter","year":"2003","journal-title":"Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0395","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0400","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/j.1471-4159.2004.02581.x","article-title":"Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein","volume":"90","author":"Irizarry","year":"2004","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.29245\/2572.942X\/2018\/4.1194","article-title":"Choroid plexus blood-CSF barrier: Major player in brain disease modeling and neuromedicine","volume":"3","author":"Johanson","year":"2018","journal-title":"Journal Neurology Neuromedicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0415","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41593-018-0238-6","article-title":"Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases","volume":"21","author":"Jucker","year":"2018","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0420","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1152\/physrev.00035.2014","article-title":"The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism","volume":"95","author":"Kambe","year":"2015","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0425","doi-asserted-by":"crossref","first-page":"19727","DOI":"10.1073\/pnas.1803521116","article-title":"RNA editing alterations define manifestation of prion diseases","volume":"116","author":"Kanata","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0430","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/176157","article-title":"Anatomy of the temporal lobe","volume":"2012","author":"Kiernan","year":"2012","journal-title":"Epilepsy Research and Treatment"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0435","article-title":"Metal ion effects on A\u03b2 and tau aggregation","volume":"19","author":"Kim","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0440","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4088\/JCP.13m08915","article-title":"Psychiatric symptoms in patients with sporadic Creutzfeldt-Jakob disease in Germany","volume":"76","author":"Krasnianski","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0445","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00415-014-7410-z","article-title":"First symptom and initial diagnosis in sporadic CJD patients in Germany","volume":"261","author":"Krasnianski","year":"2014","journal-title":"Journal of Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0450","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/704546","article-title":"Prions ex vivo: What cell culture models tell us about infectious proteins","volume":"2013","author":"Krauss","year":"2013","journal-title":"International Journal of Cell Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0455","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0460","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fphar.2012.00075","article-title":"Pathological alteration in the choroid plexus of Alzheimer\u2019s disease: Implication for new therapy approaches","volume":"3","author":"Krzyzanowska","year":"2012","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0465","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/cne.23355","article-title":"Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain","volume":"521","author":"Langlet","year":"2013","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0470","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting A\u03b2 as a modifying therapy for Alzheimer's disease: A phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: From structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0480","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brainres.2007.03.018","article-title":"Olfactory abnormalities in Huntington\u2019s disease: Decreased plasticity in the primary olfactory cortex of R6\/1 transgenic mice and reduced olfactory discrimination in patients","volume":"1151","author":"Lazic","year":"2007","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0485","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/35016089","article-title":"Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0490","series-title":"The blood-cerebrospinal fluid barrier","first-page":"211","article-title":"Regulation of neuroactive metals by the choroid plexus","author":"Li","year":"2005"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0495","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/pri.22511","article-title":"\u03b1-Cleavage of cellular prion protein","volume":"6","author":"Liang","year":"2012","journal-title":"Prion"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0500","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnagi.2014.00198","article-title":"Subtype and regional-specific neuroinflammation in sporadic creutzfeldt-jakob disease","volume":"6","author":"Llorens","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006802","article-title":"Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis","volume":"14","author":"Llorens","year":"2018","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0510","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0515","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrn3921","article-title":"Development and functions of the choroid plexus-cerebrospinal fluid system","volume":"16","author":"Lun","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0520","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1073\/pnas.0610999104","article-title":"Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles","volume":"104","author":"Manuelidis","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0525","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/NDT.S4048","article-title":"Update on the use of memantine in Alzheimer\u2019s disease","volume":"5","author":"van Marum","year":"2009","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0535","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","article-title":"CJD mimics and chameleons","volume":"17","author":"Mead","year":"2017","journal-title":"Practical Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0540","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","article-title":"Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington\u2019s disease","volume":"67","author":"Miller","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0545","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020050071","article-title":"Cerebrospinal fluid levels of transition metals in patients with Alzheimer\u2019s disease","volume":"105","author":"Molina","year":"1998","journal-title":"Journal of Neural Transmission (Vienna)"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0550","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3892\/mmr.2017.6386","article-title":"Iron and Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"15","author":"Mostile","year":"2017","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0555","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jnc.12739","article-title":"Iron dysregulation in Huntington\u2019s disease","volume":"130","author":"Muller","year":"2014","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0560","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1073858418775027","article-title":"Fluid dynamics inside the brain barrier: Current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain","volume":"25","author":"Nakada","year":"2019","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0565","doi-asserted-by":"crossref","DOI":"10.4303\/jdar\/236017","article-title":"Psycho-behavioral spiral of disturbances in prosocial behavior, stress response, and self-regulation in substance-related and addictive disorders","volume":"6","author":"Nakagawa","year":"2017","journal-title":"Journal of Drug and Alcohol Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0570","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/ph7121028","article-title":"Role of microglial M1\/M2 polarization in relapse and remission of psychiatric disorders and diseases","volume":"7","author":"Nakagawa","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0575","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2015.06.010","article-title":"Diversity and plasticity of microglial cells in psychiatric and neurological disorders","volume":"154","author":"Nakagawa","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0580","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.116.234476","article-title":"Involvement of neuroinflammation during brain development in social cognitive deficits in autism spectrum disorder and schizophrenia","volume":"358","author":"Nakagawa","year":"2016","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0585","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuint.2015.03.008","article-title":"\u03b1-Synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure","volume":"85\u201386","author":"Navarria","year":"2015","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0590","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.parkreldis.2006.08.005","article-title":"A pilot study of the clinical efficacy and safety of memantine for Huntington\u2019s disease","volume":"13","author":"Ondo","year":"2007","journal-title":"Parkinsonism & Related Disorders"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0595","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnagi.2014.00143","article-title":"Copper: From neurotransmission to neuroproteostasis","volume":"6","author":"Opazo","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0600","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1315200","article-title":"A test for Creutzfeldt-Jakob disease using nasal brushings","volume":"371","author":"Orr\u00fa","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0605","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.neubiorev.2011.12.014","article-title":"Neural and cellular mechanisms of fear and extinction memory formation","volume":"36","author":"Orsini","year":"2012","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0610","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fnagi.2018.00245","article-title":"Blood-cerebrospinal fluid barrier gradients in mild cognitive impairment and Alzheimer\u2019s disease: Relationship to inflammatory cytokines and chemokines","volume":"10","author":"Ott","year":"2018","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0615","doi-asserted-by":"crossref","DOI":"10.1038\/srep22769","article-title":"Distinctive pattern of serum elements during the progression of Alzheimer\u2019s disease","volume":"6","author":"Paglia","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0620","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0625","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00401-010-0779-6","article-title":"Phenotypic variability of sporadic human prion disease and its molecular basis: Past, present, and future","volume":"121","author":"Parchi","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0630","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2006.111203","article-title":"Physiological roles for amyloid \u03b2 peptides","volume":"575","author":"Pearson","year":"2006","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0635","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1742-2094-2-12","article-title":"Cu\/Zn superoxide dismutase expression in the postnatal rat brain following an excitotoxic injury","volume":"2","author":"Peluffo","year":"2005","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0640","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00401-005-1034-4","article-title":"Redox metals and oxidative abnormalities in human prion diseases","volume":"110","author":"Petersen","year":"2005","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0645","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/13803390600726829","article-title":"Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington\u2019s disease","volume":"29","author":"Pirogovsky","year":"2007","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0650","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1742-2094-9-188","article-title":"Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease","volume":"9","author":"Pisani","year":"2012","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0655","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.neuropharm.2011.06.018","article-title":"Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats","volume":"61","author":"Potschka","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0660","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0665","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0163-1047(79)90212-7","article-title":"The locus coeruleus, catecholamines, and REM sleep: A critical review","volume":"25","author":"Ramm","year":"1979","journal-title":"Behavioral and Neural Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0670","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2016.07.001","article-title":"How do meningeal lymphatic vessels drain the CNS?","volume":"39","author":"Raper","year":"2016","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0675","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","article-title":"Structural characterization of copper(II) binding to \u03b1-synuclein: Insights into the bioinorganic chemistry of Parkinson\u2019s disease","volume":"102","author":"Rasia","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0680","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1099\/vir.0.83281-0","article-title":"Evaluation of drugs for treatment of prion infections of the central nervous system","volume":"89","author":"Riemer","year":"2008","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0685","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: A prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0690","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","article-title":"Alterations in brain transition metals in Huntington disease: An evolving and intricate story","volume":"69","author":"Rosas","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0695","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington\u2019s disease: Complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fcell.2014.00057","article-title":"Regulation of PrPC signaling and processing by dimerization","volume":"2","author":"Roucou","year":"2014","journal-title":"Frontiers in Cell and Development Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0705","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7150\/ijms.5.347","article-title":"Prion propagation in vitro: Are we there yet?","volume":"5","author":"Ryou","year":"2008","journal-title":"International Journal of Medical Sciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0710","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/35081095","article-title":"Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding","volume":"411","author":"Saborio","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0715","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006379","article-title":"Proteolytic degradation of amyloid \u03b2-protein","volume":"2","author":"Saido","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0720","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","article-title":"Anatomy and physiology of cerebrospinal fluid","volume":"128","author":"Sakka","year":"2011","journal-title":"European Annals of Otorhinolaryngology, Head and Neck Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2019.107455_bb0725","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.3233\/JAD-2010-091387","article-title":"Caffeine intake and dementia: Systematic review and meta-analysis","volume":"20","author":"Santos","year":"2010","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0730","first-page":"1014","article-title":"Metal ions in Alzheimer\u2019s disease brain","volume":"2","author":"Sastre","year":"2015","journal-title":"JSM Alzheimer\u2019s Dis Related Dementia"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0735","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0740","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cdd.2012.72","article-title":"Ubiquitination and selective autophagy","volume":"20","author":"Shaid","year":"2013","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0745","doi-asserted-by":"crossref","DOI":"10.1038\/srep12531","article-title":"Insulin-degrading enzyme prevents \u03b1-synuclein fibril formation in a nonproteolytical manner","volume":"5","author":"Sharma","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0750","doi-asserted-by":"crossref","first-page":"46199","DOI":"10.1074\/jbc.C300303200","article-title":"Copper chelation delays the onset of prion disease","volume":"278","author":"Sigurdsson","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016804","article-title":"Decreased CSF transferrin in sCJD: A potential pre-mortem diagnostic test for prion disorders","volume":"6","author":"Singh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0760","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3233\/JAD-130218","article-title":"Prion protein regulates iron transport by functioning as a ferrireductase","volume":"35","author":"Singh","year":"2013","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000336","article-title":"Abnormal brain iron homeostasis in human and animal prion disorders","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0770","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/ars.2009.2628","article-title":"Redox control of prion and disease pathogenesis","volume":"12","author":"Singh","year":"2010","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0775","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0743-5","article-title":"Sensory circumventricular organs in health and disease","volume":"120","author":"Sis\u00f3","year":"2010","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0780","doi-asserted-by":"crossref","first-page":"158","DOI":"10.21101\/cejph.a3667","article-title":"Geographic accumulation of Creutzfeldt-Jakob disease in Slovakia: Environmental metal imbalance as a possible cofactor","volume":"19","author":"Slivarichov\u00e1","year":"2011","journal-title":"Central European Journal of Public Health"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0785","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5607\/en.2014.23.4.292","article-title":"\u03b1-Synuclein function and dysfunction on cellular membranes","volume":"23","author":"Snead","year":"2014","journal-title":"Experimental Neurobiology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0790","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0166-2236(02)02270-1","article-title":"Regulation of AMPA receptors during synaptic plasticity","volume":"25","author":"Song","year":"2002","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0795","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","article-title":"Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases","volume":"21","author":"Soto","year":"2018","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0800","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmed.2010.09.001","article-title":"The intricate mechanisms of neurodegeneration in prion diseases","volume":"17","author":"Soto","year":"2011","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002275","article-title":"Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171","volume":"7","author":"Striebel","year":"2011","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0810","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer A\u03b2 levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0815","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1113\/jphysiol.2011.225276","article-title":"Copper-dependent regulation of NMDA receptors by cellular prion protein: Implications for neurodegenerative disorders","volume":"590","author":"Stys","year":"2012","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0820","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/MAO.0b013e31822e5ba7","article-title":"Disorders affecting the fourth ventricle: Etiology and clinical correlates","volume":"32","author":"Su","year":"2011","journal-title":"Otology & Neurotology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0825","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1074\/jbc.M111.309070","article-title":"Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A)","volume":"287","author":"Sun","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0830","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123708","article-title":"Reduced CSF water influx in Alzheimer's disease supporting the \u03b2-amyloid clearance hypothesis","volume":"10","author":"Suzuki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0840","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nature Reviews. Neurology"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2019.107455_bb0845","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/bj3620253","article-title":"Metal imbalance and compromised antioxidant function are early changes in prion disease","volume":"362","author":"Thackray","year":"2002","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0850","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2013.12111460","article-title":"Behavioral and psychiatric symptoms in prion disease","volume":"171","author":"Thompson","year":"2014","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0855","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnins.2017.00003","article-title":"Metal dyshomeostasis and their pathological role in prion and prion-like diseases: The basis for a nutritional approach","volume":"11","author":"Toni","year":"2017","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0860","doi-asserted-by":"crossref","first-page":"10377","DOI":"10.1128\/JVI.01340-12","article-title":"Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: No effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35","volume":"86","author":"Tribouillard-Tanvier","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0865","doi-asserted-by":"crossref","first-page":"11244","DOI":"10.1128\/JVI.01413-09","article-title":"Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels","volume":"83","author":"Tribouillard-Tanvier","year":"2009","journal-title":"Journal of Virology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0870","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.freeradbiomed.2015.03.037","article-title":"Prion protein functions as a ferrireductase partner for ZIP14 and DMT1","volume":"84","author":"Tripathi","year":"2015","journal-title":"Free Radical Biology & Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0875","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/jnnp-2016-313541","article-title":"Doxycycline in early CJD: A double-blinded randomised phase II and observational study","volume":"88","author":"Varges","year":"2017","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0880","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jnc.14580","article-title":"Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin","volume":"147","author":"Venkataramani","year":"2018","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0885","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-2012-120244","article-title":"Copper in Alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies","volume":"30","author":"Ventriglia","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0890","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuro.2010.11.003","article-title":"Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates","volume":"32","author":"Verina","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0895","doi-asserted-by":"crossref","DOI":"10.1038\/srep20762","article-title":"Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact","volume":"6","author":"Victoria","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0900","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0905","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/jnp.17.4.489","article-title":"Psychiatric manifestations of Creutzfeldt-Jakob disease: A 25-year analysis","volume":"17","author":"Wall","year":"2005","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2017.00001","article-title":"Iron deposition leads to neuronal \u03b1-synuclein pathology by inducing autophagy dysfunction","volume":"8","author":"Wan","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0915","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0920","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/pri.24503","article-title":"Neuronal zinc regulation and the prion protein","volume":"7","author":"Watt","year":"2013","journal-title":"Prion"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0925","doi-asserted-by":"crossref","first-page":"35914","DOI":"10.1074\/jbc.M507327200","article-title":"Reactive oxygen species-mediated \u03b2-cleavage of the prion protein in the cellular response to oxidative stress","volume":"280","author":"Watt","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0930","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2135","article-title":"Prion protein facilitates uptake of zinc into neuronal cells","volume":"3","author":"Watt","year":"2012","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0935","first-page":"63","article-title":"The nutritional relationships of zinc","volume":"3","author":"Watts","year":"1988","journal-title":"Journal of Orthomolecular Medicene"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0940","first-page":"219","article-title":"The nutritional relationships of manganese","volume":"5","author":"Watts","year":"1990","journal-title":"Journal of Orthomolecular Medicene"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0945","doi-asserted-by":"crossref","first-page":"19841","DOI":"10.1074\/jbc.R114.550707","article-title":"Mouse models for studying the formation and propagation of prions","volume":"289","author":"Watts","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0950","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnins.2015.00016","article-title":"The inner CSF-brain barrier: Developmentally controlled access to the brain via intercellular junctions","volume":"9","author":"Whish","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0955","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.47.2.134","article-title":"A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features","volume":"47","author":"Will","year":"1984","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0960","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1046\/j.1471-4159.2001.00522.x","article-title":"Aberrant metal binding by prion protein in human prion disease","volume":"78","author":"Wong","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0965","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnagi.2014.00091","article-title":"Metals and cholesterol: Two sides of the same coin in Alzheimer\u2019s disease pathology","volume":"6","author":"Wong","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0970","series-title":"Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: Report of a WHO consultation","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0975","series-title":"WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0980","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12915-017-0375-5","article-title":"The biological function of the cellular prion protein: An update","volume":"15","author":"Wulf","year":"2017","journal-title":"BMC Biology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0985","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tox.2013.01.006","article-title":"Oxidative stress involvement in manganese-induced alpha-synuclein oligomerization in organotypic brain slice cultures","volume":"305","author":"Xu","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0990","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Molecular Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2019.107455_bb0995","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1074\/jbc.M400793200","article-title":"Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation","volume":"279","author":"Yadavalli","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1000","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv087","article-title":"A brief history of prions","volume":"73","author":"Zabel","year":"2015","journal-title":"Pathogens and Disease"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa022043","article-title":"Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease","volume":"348","author":"Zanusso","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12640-013-9392-5","article-title":"The role of autophagy dysregulation in manganese-induced dopaminergic neurodegeneration","volume":"24","author":"Zhang","year":"2013","journal-title":"Neurotoxicity Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1015","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s12035-013-8586-4","article-title":"Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration","volume":"49","author":"Zhang","year":"2014","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083060","article-title":"Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson\u2019s disease","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12011-012-9411-z","article-title":"Luteolin reduces zinc-induced tau phosphorylation at Ser262\/356 in an ROS-dependent manner in SH-SY5Y cells","volume":"149","author":"Zhou","year":"2012","journal-title":"Biological Trace Element Research"},{"key":"10.1016\/j.pharmthera.2019.107455_bb1030","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20151000","article-title":"A neuroprotective role for microglia in prion diseases","volume":"213","author":"Zhu","year":"2016","journal-title":"The Journal of Experimental Medicine"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819302074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819302074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:02:27Z","timestamp":1759010547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819302074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":206,"alternative-id":["S0163725819302074"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107455","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metal homeostasis disturbances in neurodegenerative disorders, with special emphasis on Creutzfeldt-Jakob disease \u2013 Potential pathogenetic mechanism and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107455"}}